How does Zepbound (tirzepatide) compare to Wegovy (semaglutide)? [ztASp9C52]

How does Zepbound (tirzepatide) compare to Wegovy (semaglutide)? [ztASp9C52]

Tirzepatide (brand name: Zepbound) is the newest injectable medication for the treatment of adults with obesity, approved by the FDA on Nov 8, 2023. Based on the results of the SURMOUNT trials, tirzepatide is the most effective obesity medication ever. This once-weekly injection produced an average weight loss of 20.9% of body weight at 72 weeks. Prior to Zepbound, Wegovy (generic: semaglutide) was the most effective weight loss medicine, with an average weight loss of 15%. In this video, Dr. Christopher McGowan, MD, MSCR, of True You Weight Loss, explains how tirzepatide (Mounjaro) works, and how it compares to Wegovy. #obesitytreatment #obesity #weightloss #weightlosstreatment #zepbound #wegovy #semaglutide #GLP1

Related Videos :

• Gina Rodriguez’s Husband Is Truly Peaceful [NOZ0pk96c]
• Zucchini Parmesan 🥒 [Lh6xah1oB]
• How to find the ICD-10-CM code for personal history of covid [e95ZAxfmn]
• Weight loss🥵 #weightloss #adventuretime #cartoon #biceps #bodybuilding #mood #gymhumor #relatable [1k5wmJ424]
• Ozempic, Mounjaro manufacturers testing weight loss drugs for kids [kIDcNKgcU]